Atea Pharmaceuticals, Inc. (AVIR)
5.145
-0.01
(-0.19%)
USD |
NASDAQ |
Oct 09, 16:00
5.145
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Net Income (Quarterly) : -32.93M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.93M |
| March 31, 2026 | -45.44M |
| December 31, 2025 | -44.87M |
| September 30, 2025 | -42.05M |
| June 30, 2025 | -37.16M |
| March 31, 2025 | -34.27M |
| December 31, 2024 | -33.54M |
| September 30, 2024 | -31.15M |
| June 30, 2024 | -40.52M |
| March 31, 2024 | -63.17M |
| December 31, 2023 | -39.16M |
| September 30, 2023 | -33.14M |
| June 30, 2023 | -28.18M |
| March 31, 2023 | -35.47M |
| December 31, 2022 | -34.43M |
| Date | Value |
|---|---|
| September 30, 2022 | -8.066M |
| June 30, 2022 | -31.34M |
| March 31, 2022 | -42.08M |
| December 31, 2021 | 117.13M |
| September 30, 2021 | -28.19M |
| June 30, 2021 | 1.539M |
| March 31, 2021 | 30.71M |
| December 31, 2020 | 20.66M |
| September 30, 2020 | -17.62M |
| June 30, 2020 | -9.993M |
| March 31, 2020 | -3.988M |
| December 31, 2019 | -4.655M |
| September 30, 2019 | -3.632M |
| June 30, 2019 | -3.554M |
| March 31, 2019 | -2.193M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| Breakthrough Chemistry, Inc. | -1.083M |
| BioStem Technologies, Inc. | -8.971M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 32.93M |
| EPS Diluted (Quarterly) | -0.4114 |
| Enterprise Value | 194.41M |
| Earnings Yield | -40.65% |
| Normalized Earnings Yield | -40.65 |